These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34241785)

  • 21. A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children.
    Zhang X; Sun R; Jia W; Li P; Song C
    Sci Rep; 2024 Apr; 14(1):8260. PubMed ID: 38589453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress in the alveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia.
    Wang M; Ren R; Xu Y; Wang T; Liang X; Li S
    Pediatr Pulmonol; 2024 Jun; ():. PubMed ID: 39031860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of quantitative MP-IgG for Mycoplasma pneumoniae pneumonia in adults.
    Wu L; Ye M; Qin X; Liu Y; Lv Z; Zheng R
    Clin Chim Acta; 2020 Apr; 503():76-83. PubMed ID: 31926153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and "early" corticosteroid treatment outcome of pediatric
    Liu J; He R; Zhang X; Zhao F; Liu L; Wang H; Zhao S
    Front Cell Infect Microbiol; 2023; 13():1135228. PubMed ID: 37082710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance.
    Lee E; Young Lee Y
    Respir Med; 2020 Dec; 175():106209. PubMed ID: 33186845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Level of D-Dimer Is Positively Correlated With the Severity of
    Zheng Y; Hua L; Zhao Q; Li M; Huang M; Zhou Y; Wang Y; Chen Z; Zhang Y
    Front Cell Infect Microbiol; 2021; 11():687391. PubMed ID: 34336714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
    Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
    BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children.
    Ling Y; Zhang T; Guo W; Zhu Z; Tian J; Cai C; Xu Y
    BMC Infect Dis; 2020 Jul; 20(1):534. PubMed ID: 32698769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemic characteristics of
    Lv YT; Sun XJ; Chen Y; Ruan T; Xu GP; Huang JA
    Ann Transl Med; 2022 Oct; 10(20):1123. PubMed ID: 36388772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Serum Interleukin-10 but not Interleukin-4 Level in Children with Mycoplasma pneumoniae Pneumonia.
    Medjo B; Atanaskovic-Markovic M; Nikolic D; Radic S; Lazarevic I; Cirkovic I; Djukic S
    J Trop Pediatr; 2017 Aug; 63(4):294-300. PubMed ID: 28057814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study.
    Choi YJ; Jeon JH; Oh JW
    Respir Res; 2019 Aug; 20(1):193. PubMed ID: 31443650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children.
    Zhang Y; Zhou Y; Li S; Yang D; Wu X; Chen Z
    PLoS One; 2016; 11(5):e0156465. PubMed ID: 27227519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of flexible bronchoscopy in children with Mycoplasma pneumoniae pneumonia.
    Wang L; Xie Q; Xu S; Li H; Zhang L; Ai J; Liu Q; Chu C; Zhang X; Zhang W; Huang L
    Pediatr Res; 2023 Jan; 93(1):198-206. PubMed ID: 35459766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children.
    Li M; Chen Y; Li H; Yang D; Zhou Y; Chen Z; Zhang Y
    BMC Infect Dis; 2021 Sep; 21(1):909. PubMed ID: 34481469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan.
    Chang CH; Tsai CK; Tsai TA; Wang SC; Lee YC; Tsai CM; Liu TY; Kuo KC; Chen CC; Yu HR
    Pediatr Neonatol; 2021 Sep; 62(5):536-542. PubMed ID: 34147432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of miR-29c/B7-H3/Th17 axis in children with Mycoplasma pneumoniae pneumonia.
    Li QL; Wu YY; Sun HM; Gu WJ; Zhang XX; Wang MJ; Yan YD; Hao CL; Ji W; Chen ZR
    Ital J Pediatr; 2019 May; 45(1):61. PubMed ID: 31088519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective study.
    Luo XQ; Luo J; Wang CJ; Luo ZX; Tian DY; Xie XH
    Pediatr Pulmonol; 2023 Oct; 58(10):2815-2822. PubMed ID: 37431970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution and Expression of IL-17 and Related Cytokines in Children with Mycoplasma pneumoniae Pneumonia.
    Fan H; Lu B; Yang D; Zhang D; Shi T; Lu G
    Jpn J Infect Dis; 2019 Nov; 72(6):387-393. PubMed ID: 31257245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribosomal RNA‑depleted RNA sequencing reveals the pathogenesis of refractory
    Huang F; Fan H; Yang D; Zhang J; Shi T; Zhang D; Lu G
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia.
    Liu J; Zhao F; Lu J; Xu H; Liu H; Tang X; Yang H; Zhang J; Zhao S
    BMC Infect Dis; 2019 Dec; 19(1):1045. PubMed ID: 31823740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.